COVID-19 testmaker Atomo pops on ASX debut

COVID-19 testmaker Atomo pops on ASX debut

Rapid blood test company Atomo Diagnostics, which has recently pivoted to supplying kits for COVID-19 antibody tests, has more its debut on the ASX at more than double its initial public offering price. It is the first float on the ASX in six weeks, since junior gold...
COVID-19 testmaker Atomo pops on ASX debut

COVID-19 puts toll traffic in slow lane

Only three of Transurban’s 17 toll roads got busier during the March quarter – and one of those was in the United States – as coronavirus restrictions slowed average daily traffic across Sydney, Melbourne and Brisbane. Car trips on nearly all the...
COVID-19 testmaker Atomo pops on ASX debut

QBE to raise $1.3bn for COVID-19 buffer

Insurance giant QBE is embarking on a $US825 million ($A1.3 billion) raising to build a buffer against the impacts of the coronavirus pandemic. The company, which also said premium growth had been strong in the first quarter, is the latest in a growing list of...
COVID-19 testmaker Atomo pops on ASX debut

Mortgage lending fell as COVID-19 loomed

The value of new home loans fell by a worse-than-expected 1.7 per cent in February even before the most serious coronavirus lockdown measures were in place. Economists had tipped the total value of housing loans to slow from 4.6 per cent growth in January as the...
COVID-19 testmaker Atomo pops on ASX debut

Gold jumps on COVID-19 stimulus measures

Gold prices surged over 2.0 per cent to a more than three-week high on Monday on expectations of global stimulus measures to counter the economic damage caused by the outbreak of the novel coronavirus. Spot gold was up 2.3 per cent at $US1,653.35 per ounce, having hit...